Literature DB >> 22528110

Biochemical isolation of insoluble tau in transgenic mouse models of tauopathies.

Carl Julien1, Alexis Bretteville, Emmanuel Planel.   

Abstract

Tau is a highly soluble microtubule-associated protein (MAP) that is abundant in the central nervous system and expressed mainly in neuronal axons. Intracellular aggregates of insoluble tau protein are present in a group of neurodegenerative diseases called tauopathies, which include Alzheimer's disease. Numerous transgenic mouse models of tauopathies have been produced in the last decade, and analysis of insoluble tau in these animals has provided a powerful tool to understand the development of tau pathology. In this short chapter, we aim at reviewing the two main isolation methods, sarkosyl and formic acid extraction (and their variations), used for the biochemical isolation of insoluble tau in transgenic mouse models of tauopathy, and discuss their advantages and drawbacks.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22528110     DOI: 10.1007/978-1-61779-551-0_32

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

1.  Familial natural short sleep mutations reduce Alzheimer pathology in mice.

Authors:  Qing Dong; Nicholas W Gentry; Thomas McMahon; Maya Yamazaki; Lorena Benitez-Rivera; Tammy Wang; Li Gan; Louis Ptáček; Ying-Hui Fu
Journal:  iScience       Date:  2022-03-15

2.  Dexmedetomidine increases tau phosphorylation under normothermic conditions in vivo and in vitro.

Authors:  Robert A Whittington; László Virág; Maud Gratuze; Franck R Petry; Anastasia Noël; Isabelle Poitras; Geoffrey Truchetti; François Marcouiller; Marie-Amélie Papon; Noura El Khoury; Kevin Wong; Alexis Bretteville; Françoise Morin; Emmanuel Planel
Journal:  Neurobiol Aging       Date:  2015-05-09       Impact factor: 4.673

3.  A three-dimensional human neural cell culture model of Alzheimer's disease.

Authors:  Se Hoon Choi; Young Hye Kim; Matthias Hebisch; Christopher Sliwinski; Seungkyu Lee; Carla D'Avanzo; Hechao Chen; Basavaraj Hooli; Caroline Asselin; Julien Muffat; Justin B Klee; Can Zhang; Brian J Wainger; Michael Peitz; Dora M Kovacs; Clifford J Woolf; Steven L Wagner; Rudolph E Tanzi; Doo Yeon Kim
Journal:  Nature       Date:  2014-10-12       Impact factor: 49.962

4.  Induced tauopathy in a novel 3D-culture model mediates neurodegenerative processes: a real-time study on biochips.

Authors:  Diana Seidel; Dana Krinke; Heinz-Georg Jahnke; Anika Hirche; Daniel Kloß; Till G A Mack; Frank Striggow; Andrea Robitzki
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

5.  Characteristics of tau oligomers.

Authors:  Yan Ren; Naruhiko Sahara
Journal:  Front Neurol       Date:  2013-07-19       Impact factor: 4.003

6.  Tau pathology induces loss of GABAergic interneurons leading to altered synaptic plasticity and behavioral impairments.

Authors:  Josien Levenga; Pavan Krishnamurthy; Hameetha Rajamohamedsait; Helen Wong; Thomas F Franke; Peter Cain; Einar M Sigurdsson; Charles A Hoeffer
Journal:  Acta Neuropathol Commun       Date:  2013-07-11       Impact factor: 7.801

7.  Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice.

Authors:  Odochi Ohia-Nwoko; Saghi Montazari; Yuen-Sum Lau; Jason L Eriksen
Journal:  Mol Neurodegener       Date:  2014-11-28       Impact factor: 14.195

8.  Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer's disease-like tau pathology.

Authors:  Maud Gratuze; Jacinthe Julien; Franck R Petry; Françoise Morin; Emmanuel Planel
Journal:  Sci Rep       Date:  2017-04-12       Impact factor: 4.379

9.  TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy.

Authors:  Shane M Bemiller; Tyler J McCray; Kevin Allan; Shane V Formica; Guixiang Xu; Gina Wilson; Olga N Kokiko-Cochran; Samuel D Crish; Cristian A Lasagna-Reeves; Richard M Ransohoff; Gary E Landreth; Bruce T Lamb
Journal:  Mol Neurodegener       Date:  2017-10-16       Impact factor: 14.195

10.  Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease.

Authors:  Cyntia Tremblay; Arnaud François; Charlotte Delay; Laure Freland; Milène Vandal; David A Bennett; Frédéric Calon
Journal:  J Neuropathol Exp Neurol       Date:  2017-02-01       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.